Alphanavi Pharma Co. Ltd., of Kyoto, Japan, was established by 1Kyoto University Innovation Capital Co. Ltd., also of Kyoto, and Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, with an investment of ¥900 million (US$8.1 million) as a carve-out business venture from Sumitomo Dainippon.